LAUSR

Venous thromboembolism (VTE) is a leading cause of preventable harm among hospitalized patients. Consequently, considerable emphasis has been placed upon increasing prescription of VTE prophylaxis; however, prophylaxis prescription does not ensure administration. Evidence suggests many doses of prescribed VTE prophylaxis are not administered in both academic and community hospitals. VTE prophylaxis non-administration has been associated with VTE. Since 2005, we have worked to improve VTE prophylaxis prescription using mandatory clinical decision support tools and prescriber performance feedback. Beginning in 2013, we have focused on interventions to improve VTE prophylaxis administration for hospitalized patients. The purpose of this study was to explore the relationship between prescription and non-administration of VTE prophylaxis in hospitalized patients. We hypothesized that nonadministration would increase as prescription increased.